Viewing Study NCT03494504


Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2026-03-28 @ 9:53 PM
Study NCT ID: NCT03494504
Status: COMPLETED
Last Update Posted: 2025-02-11
First Post: 2018-04-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
Sponsor: Aldeyra Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Allergic Conjunctivitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None reproxalap View